AI-generated analysis. Always verify with the original filing.
Co-Diagnostics, Inc. filed an 8-K on March 10, 2026, with Items N/A as stated in the document. The external hint references Item 2.02 by reference to Item 8.01 regarding Nasdaq matters, including formal notification on March 9, 2026, from The Nasdaq Stock Market LLC.
Event Type
Disclosure
Mandatory
Variant
8-K
by reference. Item 8.01. Other Events. Nasdaq Matters On March 9, 2026, Co-Diagnostics, Inc. (the “Company”) was formally notified by The Nasdaq Stock Market LL